These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18215696)

  • 1. Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease.
    Wang D; Strandgaard S; Borresen ML; Luo Z; Connors SG; Yan Q; Wilcox CS
    Am J Kidney Dis; 2008 Feb; 51(2):184-91. PubMed ID: 18215696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.
    Wang D; Strandgaard S; Iversen J; Wilcox CS
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R195-200. PubMed ID: 18685064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease.
    Raptis V; Georgianos PI; Sarafidis PA; Sioulis A; Makedou K; Makedou A; Grekas DM; Kapoulas S
    Kidney Blood Press Res; 2013; 38(1):72-82. PubMed ID: 24577239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise capacity in polycystic kidney disease.
    Reinecke NL; Cunha TM; Heilberg IP; Higa EM; Nishiura JL; Neder JA; Almeida WS; Schor N
    Am J Kidney Dis; 2014 Aug; 64(2):239-46. PubMed ID: 24787761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.
    Kocyigit I; Yilmaz MI; Orscelik O; Sipahioglu MH; Unal A; Eroglu E; Kalay N; Tokgoz B; Axelsson J; Oymak O
    Nephron Clin Pract; 2013; 123(3-4):157-64. PubMed ID: 23887359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
    Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
    Böger RH; Bode-Böger SM; Thiele W; Junker W; Alexander K; Frölich JC
    Circulation; 1997 Apr; 95(8):2068-74. PubMed ID: 9133517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.
    Kielstein JT; Böger RH; Bode-Böger SM; Frölich JC; Haller H; Ritz E; Fliser D
    J Am Soc Nephrol; 2002 Jan; 13(1):170-176. PubMed ID: 11752034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
    Kielstein JT; Böger RH; Bode-Böger SM; Schäffer J; Barbey M; Koch KM; Frölich JC
    J Am Soc Nephrol; 1999 Mar; 10(3):594-600. PubMed ID: 10073610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease.
    Wang D; Iversen J; Wilcox CS; Strandgaard S
    Kidney Int; 2003 Oct; 64(4):1381-8. PubMed ID: 12969157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria.
    Kanzelmeyer N; Tsikas D; Chobanyan-Jürgens K; Beckmann B; Vaske B; Illsinger S; Das AM; Lücke T
    Amino Acids; 2012 May; 42(5):1765-72. PubMed ID: 21472412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The L-arginine/NO pathway, homoarginine, and nitrite-dependent renal carbonic anhydrase activity in young people with type 1 diabetes mellitus.
    Carmann C; Lilienthal E; Weigt-Usinger K; Schmidt-Choudhury A; Hörster I; Kayacelebi AA; Beckmann B; Chobanyan-Jürgens K; Tsikas D; Lücke T
    Amino Acids; 2015 Sep; 47(9):1865-74. PubMed ID: 26123986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of asymmetric dimethylarginine in the regulation of nitric oxide level in rats with acute renal injury].
    Sukhovershin RA; Gilinskiĭ MA
    Ross Fiziol Zh Im I M Sechenova; 2012 Apr; 98(4):497-505. PubMed ID: 22834339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal function on homeostasis of asymmetric dimethylarginine (ADMA): studies in donors and recipients of renal transplants.
    Said MY; Douwes RM; van Londen M; Minović I; Frenay AR; de Borst MH; van den Berg E; Heiner-Fokkema MR; Kayacelebi AA; Bollenbach A; van Goor H; Navis G; Tsikas D; Bakker SJL
    Amino Acids; 2019 Mar; 51(3):565-575. PubMed ID: 30610470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function.
    Raptis V; Bakogiannis C; Loutradis C; Boutou AK; Lampropoulou I; Intzevidou E; Sioulis A; Balaskas E; Sarafidis PA
    Am J Nephrol; 2018; 47(4):231-238. PubMed ID: 29597186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and oxidative stress in polycystic kidney disease.
    Klawitter J; Reed-Gitomer BY; McFann K; Pennington A; Klawitter J; Abebe KZ; Klepacki J; Cadnapaphornchai MA; Brosnahan G; Chonchol M; Christians U; Schrier RW
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1198-206. PubMed ID: 25234311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
    Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
    J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
    Ercan M; Mungan S; Güzel I; Celik HT; Bal C; Abusoglu S; Akbulut D; Oguz EF; Yilmaz FM
    Adv Clin Exp Med; 2019 May; 28(5):693-698. PubMed ID: 30170483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.